NCT02332148View on ClinicalTrials.gov

Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis.

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2016

Conditions
Osteoarthritis of Knee
Interventions
DRUG

3VM1001

3VM1001 topical cream for treatment of osteoarthritis of the knee

DRUG

Placebo for 3VM1001

Topical cream placebo for 3VM1001; cream without 3VM1001

Sponsors

Collaborators (1)

3VM Research Group, Inc.
All Listed Sponsors
collaborator

3VM Research Group, Inc.

OTHER

lead

CDA Research Group, Inc.

INDUSTRY